Product breadth KPL offers a broad portfolio with over 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays and flow cytometry, presenting cross-sell opportunities across multiple assay workflows and research needs.

Quality signals Emphasize BacTrace native antigens and polyclonal antibodies for high signal to noise and specificity to position KPL as a trusted source for sensitive diagnostic development and assay validation.

Quality control leadership Leverage the ACCURUN and AccuPlex lines and other quality solutions for SARS-CoV-2 and HEV to target labs building or expanding molecular and antigen testing workflows, including COVID-19 and emerging pathogen testing.

Global expansion Recent and ongoing product launches since 2020 indicate a growth trajectory in molecular quality controls and reference materials, signaling opportunities to partner with clinical labs and diagnostic manufacturers investing in assay development and verification.

Scaleable partnerships Mid-market to enterprise customers in biotechnology research and diagnostics with revenues in the hundreds of millions and a solid product ecosystem present opportunities for volumes, kits, controls, and bespoke QC material sourcing across regions.